Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacology of Anaprazole in Healthy Chinese Subjects
NCT04471922Phase 1Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Mar 2019
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Anaprazole in duodenal ulcer (3 arms), sponsored by Sihuan Pharmaceutical. Primary endpoint: Number of subjects with adverse events and serious adverse events at 14 days. Started Mar 2019; status: completed.
02
Drugs
Anaprazole
03
Conditions
duodenal ulcer
Beyond the preview
Go deeper on NCT04471922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04471922.